Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Gill

Showing results (191-200 of 444) with videos related to

Pageof 45
Sort By:
HIV Clinical Trials|December 6, 2005
Effectiveness of step-wise intervention plan for managing nelfinavir-associated diarrhea: a pilot studyAnita Rachlis, John Gill, Jean-Guy Baril, et al.
AIDS (London, England)|September 27, 2014
Mortality in HIV-hepatitis C co-infected patients in Canada compared to the general Canadian population (2003-2013)Marina B Klein, Kathleen C Rollet-Kurhajec, Erica E M Moodie, et al.
The International Journal on Drug Policy|March 9, 2023
The rate of hepatitis C reinfection in Canadians coinfected with HIV and its implications for national eliminationJim Young, Shouao Wang, Charlotte Lanièce Delaunay, et al.
Virology|November 3, 2004
Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10Guido van Marle, Scot Henry, Tiona Todoruk, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 3, 2014
Virological characteristics of occult hepatitis B virus in a North American cohort of human immunodeficiency virus type 1-positive patients on dual active anti-HBV/HIV therapyCarla S Coffin, Patricia M Mulrooney-Cousins, Carla Osiowy, et al.
Journal of Viral Hepatitis|August 25, 2018
Real-world impact of direct acting antiviral therapy on health-related quality of life in HIV/Hepatitis C co-infected individualsSahar Saeed, Erica E M Moodie, Erin Strumpf, et al.
Scientific Reports|November 23, 2023
COVID-19 vaccine uptake among people with HIV: identifying characteristics associated with vaccine hesitancyKarol Boschung, M John Gill, Hartmut B Krentz, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Apollo: A comprehensive GPU-powered within-host simulator for viral evolution and infection dynamics across population, tissue, and cellDeshan Perera, Evan Li, Frank van der Meer, et al.
CJEM|May 8, 2018
Barriers and opportunities related to extracorporeal cardiopulmonary resuscitation for out-of-hospital cardiac arrest in Canada: A report from the first meeting of the Canadian ECPR Research Working GroupSteven C Brooks, Sam D Shemie, Sylvia Torrance, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 7, 2016
Timing of Antiretroviral Treatment, Immunovirologic Status, and TB Risk: Implications for Testing and TreatmentApril C Pettit, Adell Mendes, Cathy Jenkins, et al.
Pageof 45

Showing results (191-200 of 444) with videos related to

Sort By:
Pageof 45
HIV Clinical Trials|December 6, 2005
Effectiveness of step-wise intervention plan for managing nelfinavir-associated diarrhea: a pilot studyAnita Rachlis, John Gill, Jean-Guy Baril, et al.
AIDS (London, England)|September 27, 2014
Mortality in HIV-hepatitis C co-infected patients in Canada compared to the general Canadian population (2003-2013)Marina B Klein, Kathleen C Rollet-Kurhajec, Erica E M Moodie, et al.
The International Journal on Drug Policy|March 9, 2023
The rate of hepatitis C reinfection in Canadians coinfected with HIV and its implications for national eliminationJim Young, Shouao Wang, Charlotte Lanièce Delaunay, et al.
Virology|November 3, 2004
Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10Guido van Marle, Scot Henry, Tiona Todoruk, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 3, 2014
Virological characteristics of occult hepatitis B virus in a North American cohort of human immunodeficiency virus type 1-positive patients on dual active anti-HBV/HIV therapyCarla S Coffin, Patricia M Mulrooney-Cousins, Carla Osiowy, et al.
Journal of Viral Hepatitis|August 25, 2018
Real-world impact of direct acting antiviral therapy on health-related quality of life in HIV/Hepatitis C co-infected individualsSahar Saeed, Erica E M Moodie, Erin Strumpf, et al.
Scientific Reports|November 23, 2023
COVID-19 vaccine uptake among people with HIV: identifying characteristics associated with vaccine hesitancyKarol Boschung, M John Gill, Hartmut B Krentz, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Apollo: A comprehensive GPU-powered within-host simulator for viral evolution and infection dynamics across population, tissue, and cellDeshan Perera, Evan Li, Frank van der Meer, et al.
CJEM|May 8, 2018
Barriers and opportunities related to extracorporeal cardiopulmonary resuscitation for out-of-hospital cardiac arrest in Canada: A report from the first meeting of the Canadian ECPR Research Working GroupSteven C Brooks, Sam D Shemie, Sylvia Torrance, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 7, 2016
Timing of Antiretroviral Treatment, Immunovirologic Status, and TB Risk: Implications for Testing and TreatmentApril C Pettit, Adell Mendes, Cathy Jenkins, et al.
Pageof 45